Advanced Search
JIA Quan-an, ZHANG Xiao-bin, ZHANG Jie, et al. Significance of serum soluble fas ligand in patients with bladder carcinoma[J]. Cancer Research on Prevention and Treatment, 2003, 30(05): 378-379. DOI: 10.3971/j.issn.1000-8578.1434
Citation: JIA Quan-an, ZHANG Xiao-bin, ZHANG Jie, et al. Significance of serum soluble fas ligand in patients with bladder carcinoma[J]. Cancer Research on Prevention and Treatment, 2003, 30(05): 378-379. DOI: 10.3971/j.issn.1000-8578.1434

Significance of serum soluble fas ligand in patients with bladder carcinoma

  • Objective To study the significance of serum soluble Fas ligand in patients with bladder carcinoma. Methods Sandwich enzyme linked immuno-sorbent assay (ELISA) was used to detect the level of sFasL in sera of 48 bladder carcinoma patients and 25 healthy donors. Results The level of sFasL in patients with bladder carcinoma pre-operation was 12.25 ± 1.16 μg/L. It was higher than that in patients after operation and that in healthy donors( P < 0.05 ). The level of serum sFasL in patients with muscle...
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return